NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹119 Cr | ₹87 Cr | ₹58 Cr | ₹66 Cr | ₹42 Cr |
What is the latest Total Current Liabilities ratio of NGL FINECHEM ?
Year | Total Current Liabilities |
---|---|
Mar2025 | ₹119 Cr |
Mar2024 | ₹87 Cr |
Mar2023 | ₹58 Cr |
Mar2022 | ₹66 Cr |
Mar2021 | ₹42 Cr |
How is Total Current Liabilities of NGL FINECHEM Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹119 Cr | 37.40 | |
Mar2024 | ₹87 Cr | 48.54 | |
Mar2023 | ₹58 Cr | -11.21 | |
Mar2022 | ₹66 Cr | 57.19 | |
Mar2021 | ₹42 Cr | - |
Compare Total Current Liabilities of peers of NGL FINECHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NGL FINECHEM | ₹887.6 Cr | -3.1% | 12.3% | -37.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹384,002.0 Cr | -2.1% | -5.8% | -6.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹164,334.0 Cr | 3.1% | -6.5% | 28.7% | Stock Analytics | |
CIPLA | ₹127,613.0 Cr | 2.2% | 3.2% | 1.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,923.0 Cr | -1.7% | NA | 9.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,437.0 Cr | 1.4% | -1.1% | -7.6% | Stock Analytics |
NGL FINECHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NGL FINECHEM | -3.1% |
12.3% |
-37.1% |
SENSEX | -1.1% |
-1.7% |
-0.3% |
You may also like the below Video Courses